TipRanks
Go Ultimate55% OFF

Daniel Skovronsky Insider Profile

11 Followers

Daniel Skovronsky, Director at Illumina, holds 1.67K shares in Illumina (Ticker: ILMN), holds 195.51K shares in Myriad Genetics (Ticker: MYGN), holds 235.69K shares in Eli Lilly & Co (Ticker: LLY).

Daniel Skovronsky's Trading History

ILMN
Illumina
Jun 23, 2026DirectorUninformative Buy275.00K$395.05K
MYGN
Myriad Genetics
Jun 05, 2026DirectorUninformative Buy―$1.24M
LLY
Eli Lilly & Co
Feb 11, 2026EVP, CS&PO & Pres. LRLUninformative Buy16.24M$334.10M

You May Also Like

Daniel Skovronsky insider profile FAQ

What is the percentage of profitable transactions made by Daniel Skovronsky?
The percentage of profitable transactions made by Daniel Skovronsky is 100%.
What is the average return per transaction made by Daniel Skovronsky?
The average return per transaction made by Daniel Skovronsky is 47.60%.
What stocks does Daniel Skovronsky hold?
Daniel Skovronsky holds: ILMN, LLY, MYGN stocks.
What was Daniel Skovronsky’s latest transaction?
Daniel Skovronsky’s latest transaction was an Uninformative Buy of $275.00K.
What was Daniel Skovronsky's most profitable transaction?
Daniel Skovronsky’s most profitable transaction was an Informative Buy of LLY stock on August 12, 2025. The return on the trade was 92.10%.
What is Daniel Skovronsky's role in Illumina?
Daniel Skovronsky's role in Illumina is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.